C-Ray Receives FDA Acceptance of Type2 DMF for Copper-64 (Cu-64)
28 Apr 2026 //
PR NEWSWIRE
SHINE, C-Ray Therapeutics Partner For Lu-177 Supply In China
26 Mar 2026 //
PR NEWSWIRE
C-Ray Gains AAALAC Full Accreditation
24 Feb 2026 //
PR NEWSWIRE
C-Ray Therapeutics Congratulates Biokin Pharma On NMPA Approval
12 Oct 2025 //
PR NEWSWIRE
C-Ray Therapeutics Presents 225Ac-PSMA-CY313 Data At EANM 2025
08 Oct 2025 //
PR NEWSWIRE
C-Ray Backs Mednovo Ph 3 Trial, First Patient Dosed With 177Lu
10 Sep 2025 //
PR NEWSWIRE

Market Place
Sourcing Support